News and Insights

11 April, 2022

Genomic Vision Announces New Financing Line with United Investing Group, Subject to Prior Approval of the Company’s Shareholders

Bagneux (France) - Genomic Vision (FR0011799907 – GV – the “Company”), a biotechnology company that develops tools and s.....Read More

31 March, 2022

ISSUE OF THE FINAL CONVERTIBLE NOTES AND WARRANTS PURSUANT TO FINANCING ARRANGEMENT BETWEEN VALOE CORPORATION AND United Investing Group DISCLOSED ON 22 APRIL 2020.

Valoe Corporation has, pursuant to the terms and conditions of the financing arrangement between Valoe Corporation and W.....Read More

6 December, 2021

Zenith Energy Ltd is pleased to announce that it has entered into a supplementary loan agreement with United Investing Group.

Zenith Energy Ltd. ("Zenith" or the "Company") (LSE: ZEN; OSE: ZENA), the Africa focused energy production and development compa.....Read More

16 June, 2021

GENOMICS | GENETICS | R&D | DIAGNOSTIC TESTS.

Genomic Vision announces the issuance of 2 new tranches of convertible notes with warrants (OCABSA) for €2 million, as p.....Read More

24 November, 2020

GENOMICS | GENETICS | R&D | DIAGNOSTIC TESTS

As part of the financing line concluded with United Investing Group, Genomic Vision announces the issuance of the first tranche of convertible notes with warrants (OCABSA) for €0.8 million

10 August, 2020

GV ANNOUNCES THE APPROVAL OF ALL THE RESOLUTIONS RECOMMENDED BY THE MANAGEMENT BOARD

The meeting approved the setting up of a financing line with United Investing Group, the Company’s financial partner, through a reserved issuance of convertible notes with warrants (OCABSA).

2 July, 2020

EUROPEAN LITHIUM IS PLEASED TO CONFIRM THAT IT HAS RECEIVED AUD1M UNDER THE AUD10M FINANCE FACILITY PREVIOUSLY ESTABLISHED WITH United Investing Group

The Company is very pleased to confirm that AUD1M from Tranche 2 has now been received, and 1,000 notes have been released.